It’s Better Than I Thought…
A cancer diagnosis is often the first step into a world of uncertainty. And, of course, the most significant questions swirl around survival. But, until now, doctors have had little ability to give fair answers to the survival questions of cancer patients.
A new study sheds light on the issue for five-year breast cancer survivors.
As reported in the Journal of the National Cancer Institute, researchers at M.D. Anderson tracked women treated at their facility amoung 1985 and 2001. The study followed by 2,800 women who were cancer free at the five-year mark. These women had undergone surgery and radiation to remove the tumor, and soon after received follow-up treatment with either chemotherapy or hormone therapy, or the two in combination.
The researchers were pleasantly surprised with the results. Women with stage I breast cancer had
Prior to that study doctors had no substantive documents upon which to reply the question of recurrence rates. Now they believe they can supply women with accurate feedback. They plus believe the recurrence rates are much lower than most women had previously suspected.
The study did not assess the most recent cancer treatments, including aromatase inhibitors and Genentech’s Herceptin.
So, that is good news for breast cancer survivors. It appears your odds of beating the odds are looking up.
To read more about the study, see that from Reuters. To learn more about all aspects of breast cancer, see that from BreastCancer.org.
Original post by tim
No comments yet. Be the first.
Leave a reply
